13.39
price down icon1.11%   -0.15
after-market 시간 외 거래: 13.39
loading
전일 마감가:
$13.54
열려 있는:
$13.52
하루 거래량:
284.99K
Relative Volume:
0.30
시가총액:
$1.41B
수익:
-
순이익/손실:
$-115.88M
주가수익비율:
-8.6566
EPS:
-1.5468
순현금흐름:
$-104.72M
1주 성능:
-3.88%
1개월 성능:
-6.36%
6개월 성능:
-51.11%
1년 성능:
-37.31%
1일 변동 폭
Value
$13.34
$13.79
1주일 범위
Value
$13.30
$14.08
52주 변동 폭
Value
$10.60
$38.12

엣지와이즈 Stock (EWTX) Company Profile

Name
명칭
Edgewise Therapeutics Inc
Name
전화
720-262-7002
Name
주소
1715 38TH ST, BOULDER
Name
직원
117
Name
트위터
Name
다음 수익 날짜
2025-03-03
Name
최신 SEC 제출 서류
Name
EWTX's Discussions on Twitter

EWTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
EWTX
Edgewise Therapeutics Inc
13.39 1.47B 0 -115.88M -104.72M -1.5468
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

엣지와이즈 Stock (EWTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-30 개시 H.C. Wainwright Buy
2025-04-30 개시 Guggenheim Buy
2025-04-02 다운그레이드 Scotiabank Sector Outperform → Sector Perform
2025-03-07 개시 Scotiabank Sector Outperform
2025-01-22 개시 Stifel Hold
2024-11-22 개시 Evercore ISI Outperform
2024-03-07 개시 Piper Sandler Overweight
2023-05-01 개시 Truist Buy
2022-08-25 다운그레이드 Goldman Neutral → Sell
2022-04-13 개시 RBC Capital Mkts Outperform
2022-01-28 개시 Goldman Neutral
모두보기

엣지와이즈 주식(EWTX)의 최신 뉴스

pulisher
04:58 AM

What drives Edgewise Therapeutics Inc. stock priceRapid-fire capital growth - Autocar Professional

04:58 AM
pulisher
11:48 AM

Edgewise Therapeutics Inc. Stock Analysis and ForecastAccelerated investment success - Autocar Professional

11:48 AM
pulisher
Jul 20, 2025

What analysts say about Edgewise Therapeutics Inc. stockExplosive trading growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Is Edgewise Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 19, 2025
pulisher
Jul 18, 2025

When is the best time to buy Edgewise Therapeutics Inc. stockSmart Growth Low Risk Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - cnhinews.com

Jul 17, 2025
pulisher
Jul 16, 2025

why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Edgewise Therapeutics Inc. stock price move sharplyQuick Profit Idea Stream - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Edgewise Therapeutics Inc. stock performs during market volatilityShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Edgewise Therapeutics Inc. stock attracts strong analyst attentionSmart Money Signals - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 7.9%Time to Buy? - MarketBeat

Jul 12, 2025
pulisher
Jul 08, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jul 08, 2025
pulisher
Jul 07, 2025

Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment - MSN

Jul 07, 2025
pulisher
Jul 05, 2025

(EWTX) Trading Report - news.stocktradersdaily.com

Jul 05, 2025
pulisher
Jul 03, 2025

User - FinancialContent

Jul 03, 2025
pulisher
Jul 01, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by HC Wainwright - Defense World

Jul 01, 2025
pulisher
Jun 30, 2025

HC Wainwright Initiates Edgewise Therapeutics With Buy Rating, $42 Price Target - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Edgewise Therapeutics (EWTX) Initiated with Buy Rating by HC Wainwright | EWTX Stock News - GuruFocus

Jun 30, 2025
pulisher
Jun 29, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap DownHere's Why - MarketBeat

Jun 29, 2025
pulisher
Jun 28, 2025

Analysts Offer Insights on Healthcare Companies: BeiGene (ONC), Vertex Pharmaceuticals (VRTX) and Edgewise Therapeutics (EWTX) - The Globe and Mail

Jun 28, 2025
pulisher
Jun 27, 2025

Edgewise Therapeutics Shares Drop After FDA Withholds Accelerated Approval for Muscle Disorder Drug - MSN

Jun 27, 2025
pulisher
Jun 27, 2025

Edgewise Therapeutics' Regulatory Setback: A Cautionary Tale for Biotech Investors - AInvest

Jun 27, 2025
pulisher
Jun 26, 2025

Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies - WV News

Jun 26, 2025
pulisher
Jun 26, 2025

Edgewise Therapeutics stock falls after FDA deems data insufficient for accelerated approval - Investing.com UK

Jun 26, 2025
pulisher
Jun 18, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.8%Here's What Happened - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stake Boosted by GAMMA Investing LLC - MarketBeat

Jun 18, 2025
pulisher
Jun 17, 2025

Rhumbline Advisers Purchases 6,440 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Jun 17, 2025
pulisher
Jun 14, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Average PT from Analysts - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Enliven to sell $200M in stock after positive drug trial - BizWest

Jun 13, 2025
pulisher
Jun 10, 2025

Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Transcript : Edgewise Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Bank of America Corp DE Has $1.31 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 09, 2025
pulisher
Jun 08, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Receives "Outperform" Rating from Royal Bank of Canada - MarketBeat

Jun 08, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Purchases Shares of 22,584 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

Royal Bank of Canada Reaffirms Outperform Rating for Edgewise Therapeutics (NASDAQ:EWTX) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Edgewise Therapeutics (EWTX) Receives Reaffirmed 'Outperform' Ra - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

RBC Capital maintains outperform rating on Edgewise Therapeutics stock By Investing.com - Investing.com India

Jun 05, 2025

엣지와이즈 (EWTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):